Skip to main content
Clinical Trials/PACTR201805003336174
PACTR201805003336174
Recruiting
未知

An integrated health system intervention aimed at reducing type 2 diabetes risk in women after gestational diabetes in South Africa (IINDIAGO): a randomized controlled trial

Chronic Disease Initiative for Africa,0 sites370 target enrollmentApril 20, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Nutritional, Metabolic, Endocrine
Sponsor
Chronic Disease Initiative for Africa,
Enrollment
370
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 20, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Chronic Disease Initiative for Africa,

Eligibility Criteria

Inclusion Criteria

  • Women who fulfil the following criteria will be eligible for initial inclusion:
  • 1\.Diagnosed with GDM using standard criteria (specify) defined by the research team.
  • 2\.Currently living in the community served by the clinics included in the study and planning to remain in the area for the next year
  • 3\.Participant is willing and able to give informed consent for participation in the study.
  • 4\.Able to communicate in one of the predominant official languages spoken in the Western Cape (Cape Town) and Gauteng (Johannesburg) provinces (e.g. English, Afrikaans, isiXhosa, isiZulu and Sesotho)

Exclusion Criteria

  • Women with the following characteristics will not be included in the study:
  • 1\.Women who had T2DMM or type 1 diabetes prior to the index pregnancy
  • 2\.Post\-delivery, women are diagnosed with diabetes at the postpartum OGTT
  • 3\.Post\- delivery women who have stillbirths or infants who die before 6 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials